Hostname: page-component-6bf8c574d5-n2sc8 Total loading time: 0 Render date: 2025-03-04T04:33:52.084Z Has data issue: false hasContentIssue false
  • English
  • Français

An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  20 September 2021

Yael Tene ,
Katia Levytskyi ,
Amos Adler ,
Ora Halutz ,
Yael Paran ,
Hanoch Goldshmidt ,
Ayelet Itzhaki-Alfia ,
Tamar Halperin ,
Sarit Stepansky  and
Ronen Ben-Ami
...Show all authors
Yael Tene
Affiliation:
Division of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Katia Levytskyi
Affiliation:
Clinical Microbiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Amos Adler
Affiliation:
Clinical Microbiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ora Halutz
Affiliation:
Clinical Microbiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Yael Paran
Affiliation:
Division of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Hanoch Goldshmidt
Affiliation:
Division of Laboratories, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Ayelet Itzhaki-Alfia
Affiliation:
Department of Pathology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Tamar Halperin
Affiliation:
Laboratory for HIV Diagnosis, The Crusaid Kobler AIDS Center, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Sarit Stepansky
Affiliation:
Epidemiology and Infection Prevention Unit, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Ronen Ben-Ami
Affiliation:
Division of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Oryan Henig*
Affiliation:
Division of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel Epidemiology and Infection Prevention Unit, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
*
Author for correspondence: Oryan Henig, E-mail: Oryan.henig@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Real-world studies have demonstrated impressive effectiveness of the BNT162b2 COVID-19 vaccine in preventing symptomatic and asymptomatic SARS-CoV-2 infection. We describe an outbreak of SARS-CoV-2 infections in a hospital with high vaccine uptake. We found a low secondary attack rate (7%), suggesting low infectivity of vaccinated persons with vaccine breakthrough SARS-CoV-2 infections.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 1 , January 2023 , pp. 114 - 117
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Polack, FP, Thomas, SJ, Kitchin, N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383:2603–2615.CrossRefGoogle ScholarPubMed
Dagan, N, Barda, N, Kepten, E, et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021;384:1412–1423.CrossRefGoogle Scholar
Yanes-Lane, M, Winters, N, Fregonese, F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS One 2020;15(11):e0241536.CrossRefGoogle ScholarPubMed
Levine-Tiefenbrun, M, Yelin, I, Katz, R, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med 2021;27:790–792.CrossRefGoogle ScholarPubMed
Shah, A GC, Bishop, J, Hanlon, P, et al. Effect of vaccination on transmission of COVID-19: an observational study in healthcare workers and their households. N Engl J Med 2021. doi: 10.1056/NEJMc2106757.Google Scholar
Angel, Y, Spitzer, A, Henig, O, et al. Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among healthcare workers. JAMA 2021;325:2457–2465.CrossRefGoogle Scholar
COVID-19 contact tracing communications toolkit for health departments. Centers for Disease Control and Prevention website. https://wwwcdc.gov/coronavirus/2019-ncov/php/contact-tracing-commshtml. Accessed June 4, 2021.Google Scholar
Madewell, ZJ, Yang, Y, Longini, IM Jr, Halloran, ME, Dean, NE. Household transmission of SARS-CoV-2: a systematic review and meta-analysis. JAMA Netw Open 2020;3(12):e2031756.CrossRefGoogle ScholarPubMed
Walsh, KA, Jordan, K, Clyne, B, et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect 2020;81:357–371.CrossRefGoogle ScholarPubMed
Munitz, A, Yechezkel, M, Dickstein, Y, Yamin, D, Gerlic, M. BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel. Cell Rep Med 2021;2(5):100264.CrossRefGoogle ScholarPubMed